Mercer Global Advisors Inc. ADV Acquires Shares of 2,123 Chemed Co. (CHE)

Mercer Global Advisors Inc. ADV acquired a new stake in Chemed Co. (NYSE:CHE) in the 1st quarter, Holdings Channel reports. The institutional investor acquired 2,123 shares of the company’s stock, valued at approximately $680,000.

A number of other institutional investors and hedge funds have also modified their holdings of CHE. Raymond James & Associates raised its position in shares of Chemed by 20.7% during the fourth quarter. Raymond James & Associates now owns 4,814 shares of the company’s stock worth $1,364,000 after acquiring an additional 825 shares during the last quarter. First Hawaiian Bank increased its holdings in Chemed by 21.3% in the fourth quarter. First Hawaiian Bank now owns 290 shares of the company’s stock valued at $82,000 after purchasing an additional 51 shares during the last quarter. TIAA CREF Investment Management LLC increased its holdings in Chemed by 17.8% in the third quarter. TIAA CREF Investment Management LLC now owns 132,303 shares of the company’s stock valued at $42,281,000 after purchasing an additional 19,963 shares during the last quarter. Fisher Asset Management LLC increased its holdings in Chemed by 0.4% in the fourth quarter. Fisher Asset Management LLC now owns 477,261 shares of the company’s stock valued at $135,198,000 after purchasing an additional 1,961 shares during the last quarter. Finally, Legal & General Group Plc increased its holdings in Chemed by 3.4% in the third quarter. Legal & General Group Plc now owns 19,664 shares of the company’s stock valued at $6,284,000 after purchasing an additional 641 shares during the last quarter. Hedge funds and other institutional investors own 87.79% of the company’s stock.

NYSE CHE opened at $333.18 on Tuesday. The stock has a market capitalization of $5.28 billion, a P/E ratio of 27.93, a P/E/G ratio of 2.96 and a beta of 1.18. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. Chemed Co. has a 12 month low of $260.03 and a 12 month high of $335.99.

Chemed (NYSE:CHE) last released its quarterly earnings data on Monday, April 29th. The company reported $2.92 EPS for the quarter, missing analysts’ consensus estimates of $2.96 by ($0.04). Chemed had a net margin of 11.37% and a return on equity of 35.19%. The company had revenue of $462.03 million during the quarter, compared to the consensus estimate of $468.28 million. During the same quarter in the prior year, the company posted $2.72 EPS. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. On average, equities research analysts predict that Chemed Co. will post 12.65 EPS for the current year.

A number of equities research analysts recently commented on the company. Oppenheimer upped their price objective on Chemed from $340.00 to $370.00 and gave the company an “outperform” rating in a report on Tuesday, April 30th. Zacks Investment Research downgraded Chemed from a “hold” rating to a “sell” rating in a report on Friday. ValuEngine downgraded Chemed from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Finally, Royal Bank of Canada upped their price objective on Chemed from $313.00 to $318.00 and gave the company a “sector perform” rating in a report on Monday, February 25th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $347.00.

In other news, Director George J. Walsh III sold 1,000 shares of the company’s stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $328.07, for a total transaction of $328,070.00. Following the completion of the transaction, the director now directly owns 7,663 shares of the company’s stock, valued at $2,514,000.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director George J. Walsh III sold 646 shares of the company’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $326.83, for a total value of $211,132.18. Following the transaction, the director now directly owns 7,070 shares of the company’s stock, valued at $2,310,688.10. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,245 shares of company stock valued at $4,965,513. Insiders own 3.96% of the company’s stock.

WARNING: This report was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.thelincolnianonline.com/2019/05/07/mercer-global-advisors-inc-adv-acquires-shares-of-2123-chemed-co-che.html.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Story: Put Option Volume

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.